Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion type Assertion NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_head.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion description "[Since MIF participates in the inflammatory response and bladder cancer is associated with chronic inflammatory conditions, these new findings suggest that neutralizing bladder tumor MIF may serve as a novel therapeutic treatment for bladder carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_provenance.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion evidence source_evidence_literature NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_provenance.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion SIO_000772 15248897 NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_provenance.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion wasDerivedFrom befree-20140225 NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_provenance.
- NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_assertion wasGeneratedBy ECO_0000203 NP825703.RArv-F-o_Gm_ngPRGs-oQBHyrTdRgPmSfAFZfubscd5FU130_provenance.